We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LADR
501
Ladder Capital
LADR
$1.23B
-47,821
Closed -$641K
LH icon
502
Labcorp
LH
$25.8B
-20,719
Closed -$2.74M
LITE icon
503
Lumentum
LITE
$70.3B
-6,917
Closed -$395K
MDLZ icon
504
Mondelez International
MDLZ
$80.2B
-1,694,073
Closed -$73.2M
MDT icon
505
Medtronic
MDT
$111B
-482,264
Closed -$42.8M
META icon
506
Meta Platforms (Facebook)
META
$1.51T
-24,951
Closed -$3.77M
MRSN
507
DELISTED
Mersana Therapeutics
MRSN
-5,000
Closed -$1.75M
MS icon
508
Morgan Stanley
MS
$338B
-34,982
Closed -$1.56M
MSCI icon
509
MSCI
MSCI
$41.3B
-41,017
Closed -$4.22M
MSI icon
510
Motorola Solutions
MSI
$78B
-817,172
Closed -$70.9M
NBIX icon
511
Neurocrine Biosciences
NBIX
$16.7B
-21,280
Closed -$979K
NBR icon
512
Nabors Industries
NBR
$1.21B
-55,960
Closed -$22.8M
NOV icon
513
NOV
NOV
$7.08B
-1,467,818
Closed -$48.4M
NSC icon
514
Norfolk Southern
NSC
$76B
-8,928
Closed -$1.09M
OKTA icon
515
Okta
OKTA
$25.8B
-60,000
Closed -$1.37M
ORCL icon
516
Oracle
ORCL
$417B
-66,128
Closed -$3.32M
OXY icon
517
Occidental Petroleum
OXY
$55.9B
-1,143,204
Closed -$68.4M
PACB icon
518
Pacific Biosciences
PACB
$376M
-600,000
Closed -$2.14M
PBI icon
519
Pitney Bowes
PBI
$2.48B
-1,626,861
Closed -$24.6M
POST icon
520
Post Holdings
POST
$3.54B
-611,200
Closed -$31.1M
PRAA icon
521
PRA Group
PRAA
$780M
-306,618
Closed -$11.6M
PZZA icon
522
Papa John's
PZZA
$798M
-8,705
Closed -$625K
QLYS icon
523
Qualys
QLYS
$6.33B
-601,302
Closed -$24.5M
RF icon
524
Regions Financial
RF
$26.9B
-89,186
Closed -$1.31M
RGEN icon
525
Repligen
RGEN
$9.26B
-32,863
Closed -$1.36M

Similar funds

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.